A critical review of the role of endothelial factors in the pathogenesis of hypertensionSCHIFFRIN, Ernesto L.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 2, pp S3-S6Conference Paper

Endothelial factors and microvascular hypertensive diseaseRIZZONI, Damiano; AGABITI-ROSEI, Enrico.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 2, pp S15-S18Conference Paper

New insight and therapeutic strategies in cardiovascular disease and focus on endothelial target: Endothelin- 1 and anginaLERMAN, Amir.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 2, pp S27-S30Conference Paper

Current strategies and perspectives for correcting endothelial dysfunction in atherosclerosisSPIEKER, Lukas E; LÜSCHER, Thomas F; NOLL, Georg et al.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 2, pp S35-S41Conference Paper

Nitric oxide inhibition and renal alterationsJOVER, Bernard; MIMRAN, Albert.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 2, pp S65-S70Conference Paper

Endothelial dysfunction and strokeCOSENTINO, Francesco; RUBATTU, Speranza; SAVOIA, Carmine et al.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 2, pp S75-S78Conference Paper

Protective role of nebivolol in hydroxyl radical induced injuryJANSSEN, Paul M. L; ZEITZ, Oliver; RAHMAN, Alexander et al.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 3, pp S17-S23Article

Muscle sympathetic nerve activity in blood pressure control against gravitational stressMANO, Tadaaki.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 1, pp S7-S11Conference Paper

Calorie restriction reduced blood pressure in obesity hypertensives by improvement of autonomic nerve activity and insulin sensitivityNAKANO, Yukiko; OSHIMA, Tetsuya; KAMBE, Masayuki et al.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 1, pp S69-S74Conference Paper

Functional genomic research of α₁-adrenoceptorsTSUJIMOTO, Gozoh; KATSUMA, Susumu; SHIOJIMA, Satoshi et al.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 1, pp S1-S5Conference Paper

Rationale and perspective of endothelin-1 antagonism in acute heart failureKIOWSKI, Wolfgang; SUETSCH, Gabor; OECHSLIN, Erwin et al.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 2, pp S53-S57Conference Paper

Renin-angiotensin system inhibition improves coronary flow reserve in hypertensionFROHLICH, Edward D.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 37, Num 1, pp S35-S39Conference Paper

Separate modulation of neuropeptide Y₁ receptor on purinergic and on adrenergic neuroeffector transmission in canine splenic arteryYANG, Xiao-Ping; CHIBA, Shigetoshi.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 1, pp S17-S20Conference Paper

Synergistic interaction of integrin and angiotensin II in activation of extracellular signal-regulated kinase pathways in vascular smooth muscle cellsTAMURA, Kazuhiko; OKAZAKI, Masahiro; TAMURA, Masahito et al.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 1, pp S59-S62Conference Paper

Endothelin-B-receptors-dependent-inhibition of platelet aggregation in the CD-1 mouseLABONTE, Julie; BKAILY, Ghassan; D'ORLEANS-JUSTE, Pedro et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S184-S186Conference Paper

Influence of endothelin-1_(1-31) on smooth muscle tone and cholinergic nerve-mediated contraction in rat isolated tracheaGOLDIE, Roy G; D'APRILE, Angela C; SELF, Glenn J et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S228-S231Conference Paper

Characterization of the Endothelin receptor subtypes in human prostateHIRAOKA, Yasuko; OSHITA, Masafumi; MORIKAWA, Kouji et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S252-S254Conference Paper

Altered cavernosal endothelin-B-receptor binding sites in the rabbit model of partial bladder outlet obstructionTHOMPSON, Cecil S; KHAN, Masood A; DASHWOOD, Michael R et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S260-S261Conference Paper

Endothelin-receptor antagonists in uremic cardiomyopathyWOLF, Sabine C; GASCHLER, Frank; BREHM, Sibylle et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S348-S350Conference Paper

Functional significance of the isoforms of endothelin-converting enzyme-1BROWN, Carolyn D; BARNES, Kay; TURNER, Anthony J et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S26-S27Conference Paper

Evidence for downregulation of the endothelin-B-receptor by the use of fluorescent endothelin-1 and a fusion protein consisting of the endothelin-B-receptor and the green fluorescent proteinOKSCHE, Alexander; BOESE, Gregor; HORSTMEYER, Angelika et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S44-S47Conference Paper

Endothelin receptor expression in colorectal cancerALI, Haythem; DASHWOOD, Michael; DAWAS, Khaled et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S69-S71Conference Paper

Nitric oxide relaxes the vascular smooth muscle independently of endothelin-1- and U46619-induced intracellular increase of calciumBKAILY, Ghassan; SHBAKLO, Hadia; TAOUDI-BENCHEKROUN, Magda et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S110-S116Conference Paper

Biphasic release of immunoreactive endothelins following acute pulmonary thromboembolism in pigsTSANG, John; BATTISTINI, Bruno; DUSSAULT, Patrick et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S221-S224Conference Paper

Chronically elevated endothelin-1 concentrations modulate the β-adrenergic receptor system in vitro and in vivoBREHM, Bernhard R; HEINLE, Helmut; RISLER, Teut et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S157-S159Conference Paper